Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors

By Hensley Martee   Dizon Don   Derosa Felicia   Venkatraman Ennapadam   Sabbatini Paul   Chi Dennis   Dupont Jakob   Colevas A.   Spriggs David   Aghajanian Carol  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors

By Camacho Luis   Olson Jon   Tong William   Young Charles   Spriggs David   Malkin Mark  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

By Kalmadi S.   Davis M.   Dowlati A.   O’Keefe S.   Cline-Burkhardt M.   Pelley R.   Borden E.   Dreicer R.   Bukowski R.   Mekhail T.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies

By Eder Jr Joseph P.   Garcia-Carbonero Rocio   Clark Jeffrey W.   Supko Jeffrey G.   Puchalski Thomas A.   Ryan David P.   Deluca Pamela   Wozniak Antoinette   Campbell Angela   Rothermel John   LoRusso Patricia  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 139-150

Springer Publishing Company

Access to resources Recommend Favorite